17579 studies found for:    updated in the last 60 days
Show Display Options
Rank Status Study
1 Active, not recruiting Open-label Follow up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Aged 16 Years or Older Suffering From Epilepsy.
Condition: Epilepsy
Intervention: Drug: Brivaracetam
2 Active, not recruiting Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
Condition: Esophageal Carcinoma
Interventions: Drug: Tetrathiomolybdate (TM);   Procedure: Radiation;   Procedure: Surgery
3 Recruiting Pompe Disease Registry
Conditions: Glycogen Storage Disease Type II;   Pompe Disease
4 Active, not recruiting
Has Results
Therapy for Pediatric Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Drug: 12 Week Stanford V Chemotherapy;   Drug: 4 cycles of VAMP chemotherapy;   Drug: 2 alternating cycles of VAMP/COP chemotherapy;   Drug: 3 alternating cycles of VAMP/COP chemotherapy
5 Completed The Early History of Universal Screening for Metabolic Disorders
Conditions: Phenylketonuria;   Galactosemia;   Inborn Errors of Metabolism
6 Terminated A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: GM-CT-01;   Drug: 5-Fluorouracil, Leukovorin, bevacizumab
7 Recruiting Inflammatory Breast Cancer (IBC) Registry
Condition: Breast Cancer
Interventions: Other: Interview;   Procedure: Blood and Tissue Collection
8 Withdrawn Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
Condition: Kidney Diseases
Intervention: Drug: fondaparinux
9 Completed Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression
Condition: Depression
Intervention: Device: Electroconvulsive Therapy (ECT)
10 Completed Clinical Trial of Abstinence-Linked Money Management
Condition: Substance Abuse
Interventions: Behavioral: Advisor-Teller Money Manager;   Behavioral: FIT
11 Recruiting Safety of Driving After Minor Surgery With Monitored Anesthesia Care
Conditions: Minor Surgical Procedures With Monitored Anesthesia Care.;   Driving Performance After Minor Ambulatory Surgery.
Interventions: Drug: Midazolam;   Drug: Sufentanil;   Drug: Propofol
12 Completed Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
Condition: HIV Infections
Interventions: Biological: SAAVI DNA-C2 vaccine;   Biological: SAAVI MVA-C vaccine;   Biological: Placebo
13 Completed Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: letrozole;   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: questionnaire administration
14 Completed Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
15 Completed Varenicline to Reduce Alcohol Consumption in Heavy Drinkers
Condition: Alcohol Drinking
Interventions: Drug: Varenicline;   Drug: Varenicline (Chantix)
16 Active, not recruiting Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Recurrent Adult Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: bortezomib;   Drug: decitabine;   Other: pharmacological study;   Other: laboratory biomarker analysis
17 Completed
Has Results
A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)
Condition: In Vitro Fertilization
Interventions: Drug: Corifollitropin alfa;   Biological: RecFSH / Follitropin beta (Days 1 to 7);   Drug: Placebo Corifollitropin alfa;   Drug: Placebo RecFSH / follitropin beta;   Biological: RecFSH / Follitropin beta (Days 8 to hCG);   Drug: Ganirelix;   Biological: hCG;   Biological: Progesterone
18 Terminated A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors
Condition: Cancer
Intervention: Drug: ALB 109564(a) (12´-methylthiovinblastine dihydrochloride)
19 Recruiting Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China
Conditions: Influenza Type A;   Influenza Type B
Intervention: Other: Nasopharyngeal Swab
20 Withdrawn Evaluation of Remote Patient Monitoring.
Conditions: Congestive Heart Failure;   Chronic Obstructive Pulmonary Disease

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years